# Statistical Methods Coverage Analysis: Zhu et al. 2024

## Article Information

**Title:** The Importance of Biopsy Sample Length: Effects of Trans-Perineal Prostate Biopsy Length on Cancer Detection Rate

**Authors:** Zhu et al.

**Year:** 2024

**Study Design:** Retrospective cohort analysis

**Sample Size:** N = 1,202 prostate biopsy cases

**Primary Outcome:** Cancer detection (binary: detected vs. not detected)

**Cancer Detection Rate:** 40.02% (481/1,202)

**Study Period:** January 2019 - March 2022 (patients who underwent mp-MRI and trans-perineal prostate biopsy)

**Key Finding:** Minimum biopsy sample length of 11.00mm identified as optimal threshold (sensitivity 98.3%, specificity 67.4%)

---

## Study Context and Clinical Relevance

### Background
- Trans-perineal prostate biopsy is gaining acceptance as alternative to trans-rectal approach
- Previous studies showed biopsy sample length affects cancer detection rates
- No consensus on minimum acceptable sample length for trans-perineal biopsies
- Study aimed to determine optimal minimum biopsy length threshold

### Clinical Variables Examined
- **Patient characteristics:** Age, PSA level, prostate volume
- **Imaging:** mp-MRI findings (PI-RADS scores)
- **Biopsy characteristics:** Sample length, number of cores, biopsy approach
- **Outcome:** Cancer detection (yes/no)

### Statistical Challenges Addressed
1. **Group imbalance:** Patients with different characteristics between cancer-detected and non-detected groups
2. **Confounding:** Multiple patient/disease factors potentially affecting detection rate
3. **Optimal threshold determination:** Need to balance sensitivity/specificity for clinical utility
4. **Causal inference:** Establishing effect of sample length on detection after controlling for confounders

---

## Extracted Statistical Methods

### 1. Descriptive Statistics
**Location in article:** Patient characteristics table
**Purpose:** Baseline comparison between cancer-detected and non-detected groups
**Methods used:**
- Mean ¬± SD for continuous variables (age, PSA, prostate volume, sample length)
- Frequency counts and percentages for categorical variables (mp-MRI findings)
- Group comparisons (pre-matching)

### 2. Univariate Logistic Regression
**Location in article:** Initial screening of predictors
**Purpose:** Identify individual factors associated with cancer detection
**Methods used:**
- Binary logistic regression for each predictor separately
- Outcome: Cancer detection (0/1)
- Predictors tested individually:
  - Age
  - PSA level
  - Prostate volume
  - mp-MRI findings
  - Biopsy sample length
- Output: Odds ratios with 95% CIs, p-values

### 3. Propensity Score Matching
**Location in article:** Methods section - controlling for confounding
**Purpose:** Create balanced groups for fair comparison
**Specific details:**
- **Matching ratio:** 1:1
- **Tolerance:** 0.02 (caliper width)
- **Method:** Not explicitly stated (likely nearest neighbor)
- **Variables in PS model:** Age, PSA, prostate volume, mp-MRI findings
- **Assessment:** Checked balance after matching (standardized mean differences)

### 4. Multivariate Logistic Regression
**Location in article:** Main analysis after PS matching
**Purpose:** Identify independent predictors of cancer detection after controlling for confounders
**Methods used:**
- Binary logistic regression with multiple predictors
- Outcome: Cancer detection (0/1)
- Predictors entered simultaneously:
  - Age
  - PSA level
  - Prostate volume
  - mp-MRI findings
  - Biopsy sample length (main exposure of interest)
- Output: Adjusted odds ratios with 95% CIs, p-values

### 5. Pearson Correlation Analysis
**Location in article:** Exploring relationships between continuous variables
**Purpose:** Examine linear relationships between sample length and other continuous variables
**Variables correlated:**
- Biopsy sample length vs. age
- Biopsy sample length vs. PSA level
- Biopsy sample length vs. prostate volume
- Output: Correlation coefficients (r) and p-values

### 6. ROC Curve Analysis
**Location in article:** Determining optimal threshold
**Purpose:** Evaluate discriminative ability of biopsy sample length for cancer detection
**Methods used:**
- Plot ROC curve (sensitivity vs. 1-specificity)
- Calculate Area Under Curve (AUC)
- Trapezoidal rule for AUC calculation
- 95% CI for AUC (method not specified, likely DeLong)

### 7. Youden Index for Optimal Cutoff
**Location in article:** Threshold determination
**Purpose:** Identify optimal minimum sample length threshold
**Method:**
- Youden Index = Sensitivity + Specificity - 1
- Calculate for all possible thresholds
- Select threshold maximizing Youden Index
- **Result:** 11.00mm identified as optimal (sensitivity 98.3%, specificity 67.4%)

### 8. Sensitivity and Specificity Analysis
**Location in article:** Performance evaluation of 11.00mm threshold
**Purpose:** Quantify diagnostic performance at optimal cutoff
**Calculations:**
- Sensitivity = True Positives / (True Positives + False Negatives)
- Specificity = True Negatives / (True Negatives + False Positives)
- 2√ó2 confusion matrix at 11.00mm threshold

---

## ClinicoPath Jamovi Module Coverage Matrix

### Legend
- ‚úÖ **Fully Covered:** Function exists with required features
- üü° **Partially Covered:** Function exists but missing some specific features
- ‚ùå **Not Covered:** No suitable function available

---

### Coverage Analysis by Statistical Method

| Statistical Method | Coverage | Jamovi Function | Gap Analysis |
|-------------------|----------|-----------------|--------------|
| **1. Descriptive Statistics** | ‚úÖ | `tableone`, `descriptives` | **FULLY COVERED** - Multiple options for generating Table 1 with group comparisons |
| **2. Univariate Logistic Regression** | ‚úÖ | `classification` | **FULLY COVERED** - Supports binary outcomes, multiple predictors, univariate analysis mode |
| **3. Propensity Score Matching (1:1, tolerance 0.02)** | ‚úÖ | `treatmenteffects` | **FULLY COVERED** - Supports 1:1 matching, caliper specification (tolerance), balance assessment, multiple PS estimation methods |
| **4. Multivariate Logistic Regression** | ‚úÖ | `classification` | **FULLY COVERED** - Full multivariate logistic regression with adjusted ORs, 95% CIs, model diagnostics |
| **5. Pearson Correlation** | ‚úÖ | `jcorrelation`, `enhancedcorrelation` | **FULLY COVERED** - Multiple correlation analysis functions with visualization |
| **6. ROC Curve Analysis with AUC** | ‚úÖ | `enhancedROC`, `multiclassroc` | **FULLY COVERED** - Comprehensive ROC analysis with AUC, CIs, DeLong test, multiple methods |
| **7. Youden Index Optimal Cutoff** | ‚úÖ | `optimalcutpoint`, `enhancedROC` | **FULLY COVERED** - Youden Index available in both functions with performance metrics |
| **8. Sensitivity/Specificity at Threshold** | ‚úÖ | `optimalcutpoint`, `enhancedROC`, `confusionmatrix` | **FULLY COVERED** - Full diagnostic performance metrics at any threshold |

---

## Detailed Function Mapping

### 1. Descriptive Statistics ‚Üí `tableone` or `descriptives`

**Jamovi Function:** `tableone` (jamovi/tableone.a.yaml, R/tableone.b.R)

**Coverage Assessment:** ‚úÖ **FULLY COVERED**

**Features Available:**
- Mean ¬± SD for continuous variables
- Frequency (%) for categorical variables
- Group comparisons with statistical tests
- Multiple output formats (gt, gtsummary, kableExtra)
- Missing data handling
- Effect sizes
- Non-parametric alternatives

**Workflow for Zhu et al. analysis:**
```
Variables: Age, PSA, Prostate Volume, mp-MRI findings, Biopsy Length
Grouping Variable: Cancer Detection (Yes/No)
Statistical Tests: t-test (continuous), chi-square (categorical)
Output: Publication-ready Table 1
```

**Alternative:** `descriptives` module for exploratory data analysis

---

### 2. Univariate Logistic Regression ‚Üí `classification`

**Jamovi Function:** `classification` (jamovi/classification.a.yaml, R/classification.b.R)

**Coverage Assessment:** ‚úÖ **FULLY COVERED**

**Features Available:**
- Binary logistic regression
- Multiple predictors (can be analyzed one at a time)
- Odds ratios with 95% CIs
- Wald tests for coefficients
- Model diagnostics (deviance, AIC)
- Predicted probabilities
- ROC curves

**Workflow for Zhu et al. univariate analysis:**
```
Outcome: Cancer Detection (0/1)
Predictors (run separately):
  - Model 1: Age only
  - Model 2: PSA only
  - Model 3: Prostate Volume only
  - Model 4: mp-MRI findings only
  - Model 5: Biopsy Sample Length only
Output: OR, 95% CI, p-value for each predictor
```

**Notes:**
- Can run each predictor separately to replicate univariate analysis
- Option to control for covariates available for adjusted analysis

---

### 3. Propensity Score Matching ‚Üí `treatmenteffects`

**Jamovi Function:** `treatmenteffects` (jamovi/treatmenteffects.a.yaml, R/treatmenteffects.b.R)

**Coverage Assessment:** ‚úÖ **FULLY COVERED**

**Features Available:**
- Propensity score estimation (multiple methods: GLM, GAM, GBM, random forest)
- 1:1 matching with caliper (tolerance specification)
- Balance assessment:
  - Standardized mean differences (SMD)
  - Variance ratios
  - Distribution plots (pre/post matching)
- Love plots for balance visualization
- Multiple matching algorithms:
  - Nearest neighbor (likely what Zhu et al. used)
  - Optimal matching
  - Full matching
  - Genetic matching
- Treatment effect estimation (ATE, ATT)
- Sensitivity analysis

**Workflow for Zhu et al. PS matching:**
```
Treatment Variable: Biopsy Sample Length (dichotomized at some threshold)
or Cancer Detection (for creating matched groups)

Covariates in PS Model:
  - Age
  - PSA level
  - Prostate volume
  - mp-MRI findings

Matching Specification:
  - Ratio: 1:1
  - Caliper: 0.02 (2% of propensity score SD)
  - Method: Nearest neighbor without replacement

Output:
  - Matched dataset
  - Balance diagnostics (SMD before/after)
  - Treatment effect estimates
```

**Exact Match to Article:** The 1:1 matching with tolerance 0.02 is directly supported via the caliper option.

---

### 4. Multivariate Logistic Regression ‚Üí `classification`

**Jamovi Function:** `classification` (same as #2 above)

**Coverage Assessment:** ‚úÖ **FULLY COVERED**

**Features Available:**
- Full multivariate logistic regression
- Multiple predictors entered simultaneously
- Adjusted odds ratios with 95% CIs
- Wald tests for coefficients
- Likelihood ratio tests
- Model comparison (nested models)
- Multicollinearity diagnostics (VIF)
- Model fit statistics (AIC, BIC, deviance)
- Hosmer-Lemeshow goodness of fit
- Residual diagnostics
- Influential case detection

**Workflow for Zhu et al. multivariate analysis:**
```
Outcome: Cancer Detection (0/1)

All Predictors Entered Simultaneously:
  - Age
  - PSA level
  - Prostate volume
  - mp-MRI findings
  - Biopsy sample length (main exposure)

Output:
  - Adjusted OR for each predictor
  - 95% CI
  - Wald p-values
  - Overall model significance (likelihood ratio test)
  - Model fit statistics
```

**Advanced Features:**
- Can run analysis on matched dataset from step #3
- Interaction terms available if needed
- Polynomial terms for non-linear relationships
- Robust standard errors option

---

### 5. Pearson Correlation ‚Üí `jcorrelation` or `enhancedcorrelation`

**Jamovi Function:** `jcorrelation` (jamovi/jcorrelation.a.yaml, R/jcorrelation.b.R)

**Coverage Assessment:** ‚úÖ **FULLY COVERED**

**Features Available:**
- Pearson correlation coefficient
- Spearman and Kendall alternatives
- Correlation matrix for multiple variables
- P-values (two-tailed)
- 95% CIs for correlations
- Scatterplots with regression lines
- Multiple testing correction (Bonferroni, Holm, BH)
- Partial correlations
- Visualization options:
  - Correlation heatmap
  - Scatterplot matrix
  - Confidence ellipses

**Workflow for Zhu et al. correlation analysis:**
```
Variables:
  - Biopsy sample length
  - Age
  - PSA level
  - Prostate volume

Analysis:
  - Pairwise Pearson correlations
  - Focus on: Sample Length vs. each other variable

Output:
  - Correlation coefficient (r)
  - P-value
  - 95% CI
  - Scatterplots
```

**Alternative:** `enhancedcorrelation` for more advanced visualization with ggstatsplot

---

### 6. ROC Curve Analysis ‚Üí `enhancedROC` or `multiclassroc`

**Jamovi Function:** `enhancedROC` (jamovi/enhancedROC.a.yaml, R/enhancedROC.b.R)

**Coverage Assessment:** ‚úÖ **FULLY COVERED**

**Features Available:**
- ROC curve plotting
- AUC calculation with 95% CI
- Multiple CI methods:
  - DeLong (default, most accurate)
  - Bootstrap
  - Binomial exact
- Comparison of multiple ROC curves
- DeLong test for AUC differences
- Sensitivity/specificity tables
- Optimal cutoff identification (multiple criteria)
- Partial AUC calculation
- Smoothing options
- Coordinate table (all thresholds)
- Confidence bands for ROC curve

**Workflow for Zhu et al. ROC analysis:**
```
Predictor: Biopsy Sample Length (continuous)
Outcome: Cancer Detection (0/1)

Analysis:
  - Generate ROC curve
  - Calculate AUC with 95% CI (DeLong method)
  - Evaluate discriminative ability

Output:
  - ROC curve plot
  - AUC: [value] (95% CI: [lower, upper])
  - Interpretation of discrimination
```

**Advanced Features:**
- Can compare ROC curves for different predictors
- Time-dependent ROC available via `timeroc` for survival outcomes
- Multi-class extension via `multiclassroc`

---

### 7. Youden Index Optimal Cutoff ‚Üí `optimalcutpoint` or `enhancedROC`

**Jamovi Function:** `optimalcutpoint` (jamovi/optimalcutpoint.a.yaml, R/optimalcutpoint.b.R)

**Coverage Assessment:** ‚úÖ **FULLY COVERED**

**Features Available:**
- Multiple cutoff selection criteria:
  - **Youden Index (J = Sensitivity + Specificity - 1)** ‚Üê Exact match to article
  - Sensitivity = Specificity point
  - Minimize cost (with user-defined cost matrix)
  - Maximize efficiency
  - ROC01 (closest to top-left corner)
  - Index of Union
- Performance metrics at optimal cutoff:
  - Sensitivity
  - Specificity
  - PPV, NPV
  - Accuracy
  - F1 score
  - Likelihood ratios
- Bootstrap confidence intervals for cutoff
- Visualization:
  - ROC curve with optimal point marked
  - Density plots by group
  - Cutoff performance across thresholds
- Multiple cutoff comparison

**Workflow for Zhu et al. optimal cutoff:**
```
Predictor: Biopsy Sample Length (continuous)
Outcome: Cancer Detection (0/1)

Criteria: Youden Index

Analysis:
  - Calculate J for all possible thresholds
  - Select threshold maximizing J
  - Report sensitivity/specificity at optimal cutoff

Output:
  - Optimal cutoff: 11.00mm
  - Sensitivity: 98.3%
  - Specificity: 67.4%
  - Youden Index: 0.657
  - ROC curve with optimal point marked
```

**Alternative:** `enhancedROC` also includes optimal cutoff calculation with Youden Index

**Exact Match to Article:** Youden Index criterion is explicitly available and would replicate the 11.00mm threshold finding.

---

### 8. Sensitivity/Specificity at Threshold ‚Üí Multiple Functions

**Jamovi Functions:**
- `optimalcutpoint` (primary)
- `enhancedROC` (secondary)
- `confusionmatrix` (validation)

**Coverage Assessment:** ‚úÖ **FULLY COVERED**

**Features Available (`optimalcutpoint`):**
- Sensitivity and specificity at any user-defined threshold
- Sensitivity and specificity at optimal threshold (Youden or other criteria)
- Full 2√ó2 confusion matrix
- Additional performance metrics:
  - Positive predictive value (PPV)
  - Negative predictive value (NPV)
  - Accuracy
  - Balanced accuracy
  - F1 score
  - Positive likelihood ratio (LR+)
  - Negative likelihood ratio (LR-)
  - Diagnostic odds ratio (DOR)
- Bootstrap CIs for all metrics
- Visualization of performance across thresholds

**Workflow for Zhu et al. threshold evaluation:**
```
Predictor: Biopsy Sample Length (continuous)
Outcome: Cancer Detection (0/1)
Threshold: 11.00mm (from Youden analysis)

Analysis:
  - Dichotomize sample length: <11mm vs ‚â•11mm
  - Create 2√ó2 table
  - Calculate sensitivity/specificity

Expected Output:
  - Sensitivity: 98.3%
  - Specificity: 67.4%
  - 2√ó2 confusion matrix
  - PPV/NPV at threshold
```

**Alternative (`confusionmatrix`):**
- Can manually dichotomize variable at 11mm
- Create confusion matrix
- Get all performance metrics

---

## Critical Evaluation of Statistical Methods

### Evaluation Framework
Using 9-dimension scoring rubric (0-2 points each, max 18):

| Dimension | Score | Justification |
|-----------|-------|---------------|
| **1. Design-Method Alignment** | 2 | Retrospective cohort ‚Üí logistic regression is appropriate; PS matching addresses confounding effectively |
| **2. Assumptions & Diagnostics** | 1 | Logistic regression assumptions should be checked (linearity, multicollinearity); no mention of diagnostics |
| **3. Sample Size & Power** | 2 | N=1,202 with 481 events (40%) provides excellent power for logistic regression (>30 events per predictor) |
| **4. Multiplicity Control** | 1 | Multiple predictors tested but no mention of multiplicity adjustment; exploratory nature may justify this |
| **5. Model Specification** | 1 | Model includes main effects; no evaluation of interactions or non-linearity; sample length may have non-linear effect |
| **6. Missing Data Handling** | 0 | No mention of missing data assessment or handling strategy |
| **7. Effect Sizes & CIs** | 2 | Odds ratios with 95% CIs reported; appropriate effect size for logistic regression |
| **8. Validation & Calibration** | 1 | ROC analysis provides discrimination assessment; no calibration plot or external validation |
| **9. Reproducibility** | 1 | Statistical methods described but insufficient detail (PS matching algorithm not specified, no code/data sharing) |
| **TOTAL** | **11/18** | **Adequate** (61%) - Solid core methodology with room for improvement in diagnostics and transparency |

---

### Detailed Critical Assessment

#### Strengths

1. **Appropriate Primary Analysis**
   - Logistic regression is correct choice for binary outcome
   - Multivariate model controls for relevant confounders
   - Sample size is excellent (>1,000 cases with ~500 events)

2. **Propensity Score Matching**
   - Strong methodological choice to address confounding
   - 1:1 matching with caliper is appropriate
   - Balance assessment mentioned (good practice)

3. **Threshold Determination**
   - Youden Index is appropriate for balanced sensitivity/specificity
   - ROC analysis provides discrimination assessment
   - Clinical relevance considered (11mm is practical threshold)

4. **Effect Sizes with Precision**
   - Odds ratios with 95% CIs provide both magnitude and precision
   - Sensitivity/specificity at threshold with specific values (98.3%, 67.4%)

#### Limitations and Areas for Improvement

1. **Missing Model Diagnostics** (Score impact: -1 on Assumptions)
   - No mention of:
     - Linearity check for continuous predictors (e.g., restricted cubic splines)
     - Multicollinearity assessment (VIF)
     - Influential case detection (Cook's D, leverage)
     - Residual diagnostics
   - **Recommendation:** Report VIF for all predictors, check linearity with restricted cubic splines

2. **Missing Data Not Addressed** (Score impact: -2 on Missing Data)
   - No reporting of:
     - Percentage missing for each variable
     - Missing data patterns (MCAR, MAR, MNAR)
     - Handling strategy (complete case vs imputation)
   - **Concern:** Complete case analysis may introduce bias if data not MCAR
   - **Recommendation:** Report missing data percentages, use multiple imputation if >5% missing

3. **Model Specification Concerns** (Score impact: -1 on Specification)
   - **Non-linearity:** Sample length may have non-linear relationship with detection
     - Consider: Restricted cubic splines for continuous predictors
     - Consider: Polynomial terms (quadratic effect)
   - **Interactions:** No evaluation of:
     - Sample length √ó mp-MRI interaction (may detection depend on imaging findings?)
     - Sample length √ó prostate volume interaction (larger prostates need longer samples?)
   - **Recommendation:** Test non-linearity with splines, explore clinically relevant interactions

4. **Multiplicity Not Addressed** (Score impact: -1 on Multiplicity)
   - Multiple predictors tested without adjustment
   - While exploratory analysis may justify this, should be acknowledged
   - **Recommendation:** State exploratory nature or apply conservative Œ± (e.g., 0.01)

5. **Calibration Not Assessed** (Score impact: -1 on Validation)
   - ROC/AUC assesses discrimination only
   - No calibration plot or Hosmer-Lemeshow test
   - **Concern:** Model may discriminate well but have poor calibration (predicted probabilities inaccurate)
   - **Recommendation:** Report calibration plot showing observed vs predicted probabilities

6. **No External Validation** (Score impact: 0, but noteworthy)
   - Model developed and evaluated in same dataset (internal validation only)
   - Unknown generalizability to other centers/populations
   - **Recommendation:** External validation cohort or temporal validation

7. **Insufficient Reproducibility Details** (Score impact: -1 on Reproducibility)
   - PS matching algorithm not specified (nearest neighbor? optimal? greedy?)
   - Software/package versions not reported
   - No code or data sharing statement
   - **Recommendation:** Provide full statistical analysis plan, code repository, or supplementary methods

8. **Threshold Generalizability** (Conceptual concern)
   - Youden Index maximizes J in THIS sample
   - May not be optimal in populations with different prevalence
   - **Recommendation:** Sensitivity analysis across different threshold criteria, report performance across range of thresholds

---

## Statistical Method Alignment: Optimal vs. Used

| Analysis Goal | Method Used by Zhu et al. | Optimal Method | Assessment |
|--------------|---------------------------|----------------|------------|
| **Baseline comparison** | Descriptive statistics with group tests | Same | ‚úÖ Appropriate |
| **Predictor screening** | Univariate logistic regression | Same (acceptable for exploration) | ‚úÖ Appropriate |
| **Confounder control** | Propensity score matching (1:1) | PS matching or multivariate regression | ‚úÖ Appropriate (though regression alone may suffice) |
| **Independent effects** | Multivariate logistic regression | Same | ‚úÖ Appropriate |
| **Relationship exploration** | Pearson correlation | Pearson (if linear) or Spearman (if non-linear) | üü° Appropriate if linear relationship; should check |
| **Discriminative ability** | ROC curve with AUC | Same | ‚úÖ Appropriate |
| **Optimal threshold** | Youden Index | Youden (or decision curve analysis for clinical utility) | ‚úÖ Appropriate for balanced sensitivity/specificity |
| **Threshold performance** | Sensitivity/specificity | Same + PPV/NPV/LR+/LR- | üü° Should include full diagnostic metrics |

### Alternative/Complementary Methods to Consider

1. **Generalized Additive Models (GAM)** instead of linear logistic regression
   - Allows flexible non-linear relationships without pre-specifying functional form
   - Can reveal non-linear effect of sample length

2. **Decision Curve Analysis** in addition to Youden Index
   - Incorporates clinical consequences (weighing false positives vs false negatives)
   - More clinically relevant than purely statistical threshold

3. **Bootstrap Internal Validation** for model performance
   - Optimism-corrected AUC
   - Calibration slope
   - Assess overfitting

4. **Sensitivity Analysis for PS Matching**
   - Rosenbaum bounds for unmeasured confounding
   - E-value calculation
   - Assess robustness of findings

5. **Multiple Imputation** if any missing data
   - More efficient use of data
   - Reduces bias from complete case analysis

---

## Gap Analysis

### Overall Assessment: ‚úÖ **NO CRITICAL GAPS**

**All statistical methods used in Zhu et al. 2024 are fully covered by ClinicoPath jamovi module.**

### Coverage Summary
- **8/8 methods FULLY COVERED** (100%)
- **0 methods PARTIALLY COVERED**
- **0 methods NOT COVERED**

### Detailed Gap Analysis by Priority

#### Priority 1 (HIGH) - Methods Used in Article: ‚úÖ ALL COVERED
1. ‚úÖ Univariate logistic regression ‚Üí `classification`
2. ‚úÖ Multivariate logistic regression ‚Üí `classification`
3. ‚úÖ Propensity score matching (1:1, caliper 0.02) ‚Üí `treatmenteffects`
4. ‚úÖ ROC curve with AUC ‚Üí `enhancedROC`
5. ‚úÖ Youden Index optimal cutoff ‚Üí `optimalcutpoint`
6. ‚úÖ Pearson correlation ‚Üí `jcorrelation`

#### Priority 2 (MEDIUM) - Enhanced Diagnostics: üü° MOSTLY COVERED

| Enhanced Method | Status | Function | Notes |
|----------------|--------|----------|-------|
| VIF (multicollinearity) | ‚úÖ | `classification` | Available in model diagnostics |
| Hosmer-Lemeshow test | ‚úÖ | `classification` | Calibration assessment available |
| Residual diagnostics | ‚úÖ | `classification` | Deviance residuals, influential cases |
| Calibration plots | üü° | `clinicalvalidation` | Available but separate from main regression |
| Restricted cubic splines | ‚ùå | None | **MINOR GAP** - not in jamovi GUI |
| Bootstrap validation | üü° | Various functions | Available in some modules (e.g., `optimalcutpoint`) but not integrated in `classification` |

#### Priority 3 (LOW) - Advanced Extensions: üü° PARTIAL COVERAGE

| Advanced Method | Status | Function | Notes |
|----------------|--------|----------|-------|
| Decision curve analysis | ‚úÖ | `decisioncurve` | Full DCA implementation available |
| Generalized additive models (GAM) | ‚ùå | None | **MINOR GAP** - not available |
| Sensitivity analysis for PS matching | üü° | `treatmenteffects` | Has sensitivity analysis but not Rosenbaum bounds |
| Multiple imputation | ‚ùå | None | **MINOR GAP** - not available in jamovi GUI |
| External validation tools | ‚úÖ | `clinicalvalidation` | External validation framework exists |

---

## Minor Gaps Identified (Not Critical for Replicating Zhu et al.)

### GAP 1: Restricted Cubic Splines for Logistic Regression

**Priority:** LOW (not used in article, but would enhance analysis)

**Description:** Flexible modeling of non-linear relationships without pre-specifying polynomial terms

**Use Case:**
- Testing non-linear effect of biopsy sample length on cancer detection
- More flexible than quadratic/cubic polynomials
- Common in clinical prediction models

**Current Workaround:**
- Manually create polynomial terms (length¬≤, length¬≥) and add to model
- Use GAM in R (outside jamovi)

**Implementation Complexity:** Medium
- Would require adding rms package integration to `classification` module
- UI changes to add "Add spline terms" checkbox

**Clinical Impact:** Low - polynomial terms usually sufficient for practical purposes

---

### GAP 2: Bootstrap Internal Validation in Logistic Regression

**Priority:** LOW (good practice but not essential)

**Description:** Optimism-corrected performance metrics using bootstrap resampling

**Use Case:**
- Estimate optimism in model performance (AUC, calibration)
- Assess overfitting
- Provide more honest performance estimates

**Current Coverage:**
- `optimalcutpoint` has bootstrap CIs for cutoff performance
- `clinicalvalidation` has some validation metrics
- **Missing:** Integrated bootstrap validation in `classification` module

**Current Workaround:**
- Use `clinicalvalidation` module separately
- External validation in holdout sample

**Implementation Complexity:** Medium
- Would require adding bootstrap loop to `classification` module
- Computational intensity (may be slow for large datasets)

**Clinical Impact:** Low - external validation is gold standard anyway

---

### GAP 3: Multiple Imputation

**Priority:** LOW (not discussed in article)

**Description:** Handling missing data through multiple imputation (MI)

**Current Coverage:**
- ‚ùå No MI implementation in ClinicoPath
- Users must handle missing data before analysis (complete case or external imputation)

**Use Case:**
- Reduce bias from complete case analysis when data MCAR/MAR
- Increase efficiency (larger effective sample size)

**Current Workaround:**
- Complete case analysis (jamovi default)
- Perform MI in R using mice package, then import complete datasets

**Implementation Complexity:** HIGH
- Would require major new module for MI workflow
- Complex UI for specifying imputation models
- Need to handle pooling of results across imputations
- Storage of multiple datasets

**Clinical Impact:** Low-Medium - depends on extent of missing data

**Recommendation:** LOW PRIORITY - users with substantial missing data can use R directly

---

### GAP 4: Generalized Additive Models (GAM)

**Priority:** LOW (alternative modeling approach)

**Description:** Semi-parametric regression allowing flexible non-linear effects

**Use Case:**
- Exploring complex non-linear relationships
- Alternative to pre-specifying polynomial/spline terms

**Current Coverage:**
- ‚ùå Not available in jamovi
- Can use polynomial terms in `classification` as simpler alternative

**Current Workaround:**
- Use polynomial terms
- Use GAM in R directly (mgcv package)

**Implementation Complexity:** HIGH
- Would require new module
- Complex UI for smoothing parameter selection
- Interpretation more challenging for clinical users

**Clinical Impact:** Low - rarely essential for clinical research

**Recommendation:** LOW PRIORITY - polynomial terms in logistic regression usually sufficient

---

## Implementation Roadmap

### Priority Assessment: ‚úÖ **NO IMPLEMENTATION NEEDED**

**Rationale:**
- All 8 statistical methods used in Zhu et al. 2024 are FULLY COVERED
- The 4 minor gaps identified are:
  1. Not used in the article
  2. Enhancement features rather than core functionality
  3. Low clinical impact
  4. Have acceptable workarounds

**Recommendation:**
- **No new development required to replicate Zhu et al. analysis**
- ClinicoPath module is fully capable of conducting identical analysis
- Minor gaps could be considered for future enhancement but are NOT blocking

---

### If Future Enhancement Desired (Low Priority)

#### Phase 1: Quick Wins (If Desired)
**None - all core functionality exists**

#### Phase 2: Model Diagnostics Enhancement (Optional)
**Target:** Integrate advanced diagnostics into `classification` module

**Estimated Effort:** 2-3 days

**Features to add:**
1. Restricted cubic spline terms (using rms::rcs())
   - Add UI checkbox "Use spline terms for continuous predictors"
   - Add option for number of knots (default: 3)
2. Bootstrap internal validation (using rms::validate())
   - Add UI checkbox "Bootstrap validation (500 iterations)"
   - Report optimism-corrected AUC and calibration slope

**Implementation sketch:**

```yaml
# In classification.a.yaml - add options:
- name: use_splines
  title: Use restricted cubic splines for continuous predictors
  type: Bool
  default: false

- name: n_knots
  title: Number of knots
  type: Integer
  min: 3
  max: 7
  default: 3

- name: bootstrap_validation
  title: Bootstrap internal validation
  type: Bool
  default: false

- name: n_bootstrap
  title: Number of bootstrap samples
  type: Integer
  default: 500
```

```r
# In classification.b.R - add method:
.applySplines = function() {
    if (self$options$use_splines) {
        continuous_vars <- # identify continuous predictors
        for (var in continuous_vars) {
            # Use rms::rcs() to create spline terms
            formula <- update(formula,
                              as.formula(paste0("~ . - ", var, " + rms::rcs(", var, ", ", self$options$n_knots, ")")))
        }
    }
    return(formula)
}

.performBootstrapValidation = function(model) {
    if (self$options$bootstrap_validation) {
        # Use rms::validate.lrm() or manual bootstrap
        boot_results <- rms::validate(model, B = self$options$n_bootstrap)
        # Extract optimism-corrected AUC, calibration slope
        # Populate results table
    }
}
```

**Expected Impact:**
- Enhanced modeling flexibility
- Better assessment of overfitting
- More rigorous performance estimates

#### Phase 3: Missing Data Handling (Future Consideration)
**Target:** New module for multiple imputation workflow

**Estimated Effort:** 1-2 weeks

**Not recommended for near-term development:**
- High complexity
- Users can handle MI externally if needed
- Low frequency of need in typical jamovi workflows

---

## Jamovi Workflow to Replicate Zhu et al. Analysis

### Complete Step-by-Step Guide

#### **Step 1: Data Preparation**
**Required variables:**
- `age` (continuous)
- `psa_level` (continuous)
- `prostate_volume` (continuous)
- `mpmri_findings` (categorical or continuous, e.g., PI-RADS score)
- `biopsy_length` (continuous, in mm)
- `cancer_detected` (binary: 0 = No, 1 = Yes)

**Data cleaning:**
- Check for missing data (if >5%, consider external imputation)
- Check for outliers (boxplots)
- Verify variable types (continuous vs categorical)

---

#### **Step 2: Descriptive Statistics**

**Module:** `tableone`

**Navigation:** ClinicoPath Descriptives ‚Üí Table One

**Settings:**
- Variables: Age, PSA Level, Prostate Volume, mp-MRI Findings, Biopsy Length
- Grouping Variable: Cancer Detected
- Statistics:
  - Continuous: Mean ¬± SD, median [IQR]
  - Categorical: N (%)
- Statistical Tests:
  - Continuous: Independent t-test (or Mann-Whitney if non-normal)
  - Categorical: Chi-square test
- Effect Sizes: ‚úì Include (Cohen's d for continuous)

**Output:**
- Table 1 with baseline characteristics
- P-values for group differences

**Expected Result:** Similar to patient characteristics table in article

---

#### **Step 3: Univariate Logistic Regression**

**Module:** `classification`

**Navigation:** ClinicoPath Descriptives ‚Üí Classification / Prediction ‚Üí Binary Classification

**For each predictor separately (run 5 times):**

**Model 1 - Age:**
- Outcome: `cancer_detected`
- Predictors: `age`
- Options:
  - ‚úì Odds ratios with 95% CI
  - ‚úì Wald test for coefficients

**Model 2 - PSA:**
- Outcome: `cancer_detected`
- Predictors: `psa_level`

**Model 3 - Prostate Volume:**
- Outcome: `cancer_detected`
- Predictors: `prostate_volume`

**Model 4 - mp-MRI:**
- Outcome: `cancer_detected`
- Predictors: `mpmri_findings`

**Model 5 - Biopsy Length:**
- Outcome: `cancer_detected`
- Predictors: `biopsy_length`

**Output from each model:**
- OR with 95% CI
- Wald p-value
- Deviance, AIC

**Expected Result:** Identify predictors with p < 0.05 for multivariate model

---

#### **Step 4: Propensity Score Matching**

**Module:** `treatmenteffects`

**Navigation:** Medical Decision Analysis ‚Üí Treatment Effects / Propensity Scores

**Settings:**
- Treatment Variable: Define based on study design
  - Option A: Dichotomize biopsy length (e.g., <11mm vs ‚â•11mm) if comparing groups by length
  - Option B: Use cancer_detected as treatment (to balance groups for comparison)
- Confounders (for PS model):
  - `age`
  - `psa_level`
  - `prostate_volume`
  - `mpmri_findings`
- Matching Options:
  - Method: Nearest neighbor
  - Ratio: 1:1
  - Caliper: 0.02 (2% of propensity score SD)
  - Replacement: No
- Balance Assessment:
  - ‚úì Standardized mean differences (SMD)
  - ‚úì Love plot
  - Target: SMD < 0.1 for good balance

**Output:**
- Matched dataset (save as new dataset)
- Balance diagnostics table
- Love plot showing before/after matching
- Treatment effect estimate

**Expected Result:** Balanced groups with SMD < 0.1 for all covariates

---

#### **Step 5: Multivariate Logistic Regression (on Matched Data)**

**Module:** `classification`

**Use:** Matched dataset from Step 4

**Settings:**
- Outcome: `cancer_detected`
- Predictors (all entered simultaneously):
  - `age`
  - `psa_level`
  - `prostate_volume`
  - `mpmri_findings`
  - `biopsy_length` (main exposure of interest)
- Options:
  - ‚úì Adjusted odds ratios with 95% CI
  - ‚úì Wald tests
  - ‚úì Model fit statistics (AIC, deviance)
  - ‚úì VIF (check multicollinearity, VIF < 10)
  - ‚úì Hosmer-Lemeshow test (calibration)
  - ‚úì Residual diagnostics

**Output:**
- Adjusted OR for each predictor with 95% CI
- Wald p-values
- Overall model test (likelihood ratio)
- Model fit: AIC, deviance, pseudo-R¬≤
- VIF values
- Hosmer-Lemeshow p-value (>0.05 indicates good fit)

**Expected Result:**
- Independent effect of biopsy length on cancer detection
- OR > 1 indicates longer samples increase detection probability

---

#### **Step 6: Pearson Correlation Analysis**

**Module:** `jcorrelation`

**Navigation:** ClinicoPath Descriptives ‚Üí Correlation Analysis ‚Üí Correlation Matrix

**Settings:**
- Variables:
  - `biopsy_length`
  - `age`
  - `psa_level`
  - `prostate_volume`
- Method: Pearson
- Options:
  - ‚úì Correlation coefficients
  - ‚úì P-values (two-tailed)
  - ‚úì 95% confidence intervals
  - ‚úì Scatterplot matrix
  - ‚úì Correlation heatmap

**Output:**
- Correlation matrix with r values
- P-values for each correlation
- 95% CIs
- Scatterplots with regression lines

**Expected Result:**
- Examine relationships between sample length and other variables
- Identify potential multicollinearity issues

---

#### **Step 7: ROC Curve Analysis**

**Module:** `enhancedROC`

**Navigation:** Medical Decision Analysis ‚Üí ROC Curves ‚Üí Enhanced ROC Analysis

**Settings:**
- Predictor: `biopsy_length` (continuous)
- Outcome: `cancer_detected` (binary, code 1 = cancer)
- Options:
  - ‚úì Plot ROC curve
  - ‚úì Calculate AUC with 95% CI
  - CI Method: DeLong
  - ‚úì Coordinate table (sensitivity/specificity at all thresholds)
  - ‚úì Identify optimal cutoff (see Step 8)

**Output:**
- ROC curve plot
- AUC with 95% CI (expect >0.80 for good discrimination)
- Sensitivity/specificity table across thresholds

**Expected Result:**
- AUC indicating discriminative ability of sample length
- Visual assessment of model performance

---

#### **Step 8: Optimal Cutoff with Youden Index**

**Module:** `optimalcutpoint`

**Navigation:** Medical Decision Analysis ‚Üí Optimal Cutpoint Analysis

**Settings:**
- Predictor: `biopsy_length` (continuous)
- Outcome: `cancer_detected` (binary)
- Optimization Criterion: **Youden Index** (Sensitivity + Specificity - 1)
- Options:
  - ‚úì Calculate performance metrics at optimal cutoff
  - ‚úì Bootstrap confidence intervals (1000 iterations)
  - ‚úì ROC curve with optimal point marked
  - ‚úì Density plots by group
  - ‚úì Performance table across thresholds

**Output:**
- **Optimal cutoff:** Expected 11.00mm (or close)
- **Youden Index (J):** Maximum value
- **Sensitivity:** Expected ~98.3%
- **Specificity:** Expected ~67.4%
- Additional metrics:
  - PPV, NPV
  - Accuracy
  - F1 score
  - Likelihood ratios (LR+, LR-)
- ROC curve with optimal cutoff highlighted
- Performance across threshold range

**Expected Result:**
- Cutoff of ~11mm with high sensitivity and moderate specificity
- Matches article finding of 11.00mm threshold

---

#### **Step 9: Sensitivity/Specificity at 11mm Threshold**

**Module:** `confusionmatrix` (optional validation)

**Settings:**
1. Create dichotomous variable:
   - Transform ‚Üí Compute Variable
   - `length_adequate = ifelse(biopsy_length >= 11, 1, 0)`

2. Generate confusion matrix:
   - Predicted: `length_adequate`
   - Actual: `cancer_detected`

**Output:**
- 2√ó2 confusion matrix
- Sensitivity = True Positives / (TP + FN)
- Specificity = True Negatives / (TN + FP)
- PPV = TP / (TP + FP)
- NPV = TN / (TN + FN)
- Accuracy = (TP + TN) / Total

**Expected Result:** Confirm sensitivity ~98.3%, specificity ~67.4%

---

### Summary of Workflow

| Step | Module | Analysis | Expected Output |
|------|--------|----------|-----------------|
| 1 | Data prep | Variable checking | Clean dataset |
| 2 | `tableone` | Descriptive statistics | Table 1 with group comparisons |
| 3 | `classification` | Univariate logistic regression (√ó5) | OR, 95% CI, p-value for each predictor |
| 4 | `treatmenteffects` | Propensity score matching (1:1, 0.02 caliper) | Matched dataset, balance diagnostics |
| 5 | `classification` | Multivariate logistic regression | Adjusted OR for all predictors |
| 6 | `jcorrelation` | Pearson correlations | Correlation matrix with sample length |
| 7 | `enhancedROC` | ROC curve & AUC | Discrimination assessment |
| 8 | `optimalcutpoint` | Youden Index cutoff | Optimal threshold (11mm), sens/spec |
| 9 | `confusionmatrix` | Performance at 11mm | Validation of sensitivity/specificity |

---

## Conclusion

### Coverage Assessment: ‚úÖ **EXCELLENT - FULL COVERAGE**

**The ClinicoPath jamovi module provides complete coverage for all statistical methods used in Zhu et al. 2024.**

### Key Findings

1. **8/8 Methods Fully Covered (100%)**
   - All core analyses can be replicated exactly
   - No critical gaps identified
   - Appropriate functions exist for each method

2. **Quality of Implementation**
   - Functions provide all necessary features
   - Options match article specifications (e.g., 1:1 PS matching with 0.02 caliper)
   - Output includes all required metrics

3. **Minor Enhancement Opportunities (Low Priority)**
   - Restricted cubic splines in logistic regression
   - Bootstrap internal validation
   - Multiple imputation
   - Generalized additive models
   - **Note:** These are not needed to replicate Zhu et al. analysis

4. **Workflow Feasibility**
   - Complete 9-step workflow documented
   - All steps achievable within jamovi GUI
   - Expected time: 2-3 hours for complete analysis
   - No external software required

### Statistical Method Quality: üü° **ADEQUATE (11/18)**

The article uses appropriate core methods but could be strengthened with:
- Model diagnostic reporting (VIF, linearity checks)
- Missing data assessment
- Calibration evaluation
- More detailed reproducibility information

However, these limitations do not prevent replication in ClinicoPath.

### Recommendation

**No new development required.** The ClinicoPath jamovi module is fully equipped to conduct identical statistical analyses to Zhu et al. 2024.

**For Users:** Follow the 9-step workflow documented above to replicate the analysis.

**For Developers:** Consider low-priority enhancements (splines, bootstrap validation) for future versions, but these are not blocking issues.

---

## References

**Article Analyzed:**
Zhu et al. (2024). The Importance of Biopsy Sample Length: Effects of Trans-Perineal Prostate Biopsy Length on Cancer Detection Rate. [Journal information not provided in text file]

**Relevant ClinicoPath Functions:**
- `tableone` (jamovi/tableone.a.yaml, R/tableone.b.R)
- `classification` (jamovi/classification.a.yaml, R/classification.b.R)
- `treatmenteffects` (jamovi/treatmenteffects.a.yaml, R/treatmenteffects.b.R)
- `jcorrelation` (jamovi/jcorrelation.a.yaml, R/jcorrelation.b.R)
- `enhancedROC` (jamovi/enhancedROC.a.yaml, R/enhancedROC.b.R)
- `optimalcutpoint` (jamovi/optimalcutpoint.a.yaml, R/optimalcutpoint.b.R)
- `confusionmatrix` (jamovi/confusionmatrix.a.yaml, R/confusionmatrix.b.R)

**Statistical References:**
- DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988). Comparing the areas under two or more correlated receiver operating characteristic curves. Biometrics, 44(3), 837-845.
- Youden, W. J. (1950). Index for rating diagnostic tests. Cancer, 3(1), 32-35.
- Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41-55.
- Austin, P. C. (2011). Optimal caliper widths for propensity-score matching. American Journal of Epidemiology, 173(5), 477-489.
- Hosmer, D. W., Lemeshow, S., & Sturdivant, R. X. (2013). Applied Logistic Regression (3rd ed.). Wiley.

---

## Appendix: Function Catalog from Jamovi Module

### ROC Curve Analysis Functions
- `enhancedROC` - Comprehensive ROC analysis with multiple CI methods
- `ordinalroc` - Ordinal outcome ROC curves
- `multiclassroc` - Multi-class classification ROC
- `rocreg` - ROC regression (covariate-adjusted)
- `timeroc` - Time-dependent ROC for survival outcomes
- `precisionrecall` - Precision-recall curves

### Correlation Analysis Functions
- `jcorrelation` - Correlation matrix with multiple methods
- `enhancedcorrelation` - Advanced correlation with ggstatsplot
- `partialcorrelation` - Partial and semi-partial correlations

### Logistic Regression Functions
- `classification` - Binary/multinomial logistic regression
- `clinicalvalidation` - Model validation and calibration
- `directregression` - General linear models

### Propensity Score / Causal Inference Functions
- `treatmenteffects` - Comprehensive PS analysis with matching

### Model Performance Functions
- `modelperformance` - Model fit statistics and diagnostics
- `concordanceindex` - C-index for prediction models

### Optimal Cutoff Functions
- `optimalcutpoint` - Multiple optimization criteria including Youden
- `enhancedROC` - Includes optimal cutoff identification

### Confusion Matrix Functions
- `confusionmatrix` - Binary classification performance metrics

---

**Document Generated:** 2025-10-28
**Analysis Tool:** ClinicoPath Jamovi Module Review System
**Analyst:** Claude Code (Anthropic)
